Sharemaestro Newsreel

Sonoma Pharmaceuticals Inc (SNOA) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides an overview of the shareholder structure of Sonoma Pharmaceuticals Inc (SNOA), detailing major shareholders and institutional holdings. It lists the proportion of shares held by entities like DRW Securities, Vanguard Capital Management, and Geode Capital Management, as well as various shareholder …

Xeris Biopharma Holdings Inc (XERS) Earnings Forecast: Future EPS & Revenue Growth Estimates

Xeris Biopharma Holdings Inc (XERS) has an earnings forecast score of 8.57, ranking 26th in the Pharmaceuticals industry. Analysts have an average price target of $10.00 for XERS, with a consensus "Buy" rating based on 7 analysts. The expected revenue for the next quarter …

Talphera Inc (TLPH) Institutional Confidence

Talphera Inc (TLPH) has an institutional shareholding score of 3.00, placing it 92nd out of 155 in the Pharmaceuticals industry. The institutional shareholding proportion is 40.00%, showing a 0.70% quarter-over-quarter increase. James Simons is the largest institutional shareholder, holding 0.48% of outstanding shares.

Tilray Brands Inc (TLRY) Institutional Confidence

The article discusses the institutional confidence score for Tilray Brands Inc (TLRY), which currently stands at 3.00, ranking 92 out of 155 in the Pharmaceuticals industry. Institutional shareholding is 9.89%, a 16.13% decrease from the previous quarter. The largest institutional shareholder is Bill Nygren …

Should Teva’s Branded-Drug Pivot and Duvakitug Bet Reshape How TEVA Investors View Earnings Power?

Teva Pharmaceutical Industries is shifting its focus from generics to higher-margin branded drugs, with a significant bet on duvakitug for ulcerative colitis and Crohn's disease, which could be a multi-billion-dollar opportunity. This pivot, alongside other branded neurology and psychiatry initiatives, aims to reshape investor …

Neurocrine’s 33% quarter outruns weak drugmaker breadth, but average volume keeps the move under review

NBIX closed at $175.8, just 3.0% below its 52-week high, with an active weekly Trend Signal and positive Market Dynamics. The reservation is participation, with latest volume at only 1.0x the 13-week average.

Regencell Bioscience Holdings Limited Revenue Breakdown – NASDAQ:RGC

OrganiGram Holdings Inc (OGI) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for OrganiGram Holdings Inc (OGI), noting its current score of 3.09 and ranking within the Healthcare Providers & Services industry. It highlights the stock's beta of 1.87, indicating higher volatility compared to the S&P 500, and details various …

Gelteq Ltd (GELS) Valuation: PE, PB & Fair Value Analysis

This article provides a brief valuation analysis for Gelteq Ltd (GELS), focusing on its stock performance and key financial ratios like P/E, P/B, and P/CF. The data indicates that relevant information for these valuation metrics has not yet been disclosed by the company. Gelteq …

TKNO|Alpha Teknova Inc|Price:4.840|Chg%:-0.130

This article provides a detailed financial overview of Alpha Teknova Inc. (TKNO), presenting its income statement, balance sheet, and cash flow statement. It highlights key financial indicators, earnings data, and analyst ratings, alongside answers to frequently asked questions about the company's financial performance.

OrganiGram Holdings Inc (OGI) Institutional Confidence

This article from TradingKey provides an overview of institutional confidence in OrganiGram Holdings Inc (OGI), detailing key institutional shareholders and their recent activity. It lists the top institutional holders, including British American Tobacco P.l.c. and Renaissance Technologies LLC, along with changes in their shareholdings. …

IM Cannabis Says Alon Dayan Resigned for Personal Reasons

IM Cannabis (Nasdaq: IMCC) announced that director Alon Dayan resigned from its board for personal reasons. The company's board and management thanked him for his contributions. IM Cannabis operates a medical cannabis platform in Israel and Germany, and its stock saw a mild positive …

Aurora Cannabis Inc (ACB) Income Statement

This article provides a detailed income statement for Aurora Cannabis Inc (ACB), including quarterly and annual financial performance data. It outlines key metrics such as total revenue, cost of revenue, operating expenses, and net income, alongside their year-over-year changes. The document also includes an …

IM Cannabis Provides Corporate Update

IM Cannabis Corp. (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announced the resignation of Mr. Alon Dayan from its board of directors due to personal reasons. The company expressed gratitude for his contributions and wished him well. IM Cannabis …

Dr Reddy's Laboratories Ltd (RDY) Q1 2027 Earnings Call Highlights: Navigating Challenges and ...

This article first appeared on GuruFocus. Revenue: INR8,071 crores (USD853 million), a decline of 5.6% year-over-year, growth of 7.4% sequentially. EBITDA Margin: 12.5%, impacted by semaglutide API-related challenges; excluding this, margin was 15.4%. Gross Profit Margin: 46.5%, a decrease of 1,039 basis points year-over-year, …

Viatris Inc (VTRS) Income Statement

This article provides the quarterly and annual income statements for Viatris Inc (VTRS), offering detailed financial data such as total revenue, cost of revenue, operating expenses, operating profit, net income, and earnings per share (EPS). It includes year-over-year percentage changes and absolute figures across …

Liquidia Corporation (LQDA) Has 50%+ Upside on Yutrepia Ruling and Buyout Potential

Buckley Capital Advisors, in its Q2 2026 investor letter, highlighted Liquidia Corporation (NASDAQ:LQDA) as a significant contributor to its portfolio, despite its substantial appreciation. The firm still sees over 50% upside, anticipating a favorable Yutrepia product ruling and potential acquisition. Liquidia is a biopharmaceutical …

Amneal Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:AMRX

Return on assets % of Ironwood Pharmaceuticals, Inc. Class A – HAM:I76

The article provides financial data specifically focusing on the Return on Assets (%) for Ironwood Pharmaceuticals, Inc. Class A, traded under the symbol I76 on the Hamburg Stock Exchange. It indicates historical values and changes for this metric, noting that the market is currently …

HLN|Haleon PLC|Price:10.280|Chg%:+0.340

This article provides a comprehensive stock analysis of Haleon PLC (HLN), highlighting its healthy fundamentals, high growth potential, and fairly valued status within the Pharmaceuticals industry. It notes high institutional ownership and recent "Buy" ratings from analysts with a target price of $10.63. The …

LNTH Stock Drops After-Hours As Curium's $7B Offer Comes In Below Market Value

Shares of Lantheus Holdings Inc. (LNTH) dropped 3% in after-hours trading following reports that Curium is in advanced talks to acquire the radiopharmaceutical firm for $7 billion. The offer, which includes an upfront payment of roughly $102 per share plus contingent value rights, is …

BioXcel Therapeutics Inc (BTAI) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of BioXcel Therapeutics Inc's (BTAI) dividend and stock split history. It notes that the company has not distributed any dividends over the past five years. The article also details several merger-related stock splits scheduled for February 6, 2025, each …

IM Cannabis director Alon Dayan resigns from board By Investing.com

IM Cannabis Corp. announced that director Alon Dayan has resigned from its board for personal reasons. The medical cannabis company, which operates in Israel and Germany, has not yet named a replacement. The company thanked Dayan for his service and is evaluating expansion opportunities …

Zoetis (ZTS) Beats Stock Market Upswing: What Investors Need to Know

Zoetis (ZTS) closed at $76.92 in the latest trading session, marking a +2.08% move from the prior day. This move outpaced the S&P 500's daily gain of 0.02%. On the other hand, the Dow registered a gain of 0.51%, and the technology-centric Nasdaq decreased …

IM Cannabis (Nasdaq: IMCC) discloses board resignation and corporate update

IM Cannabis Corp. announced the resignation of director Alon Dayan, effective July 26, 2026, citing personal reasons unrelated to company policies. The company, which operates a medical cannabis platform in Israel and Germany, also provided a corporate update on its operations, including importing, distributing, …

Lifecore Biomedical Inc (LFCR) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Lifecore Biomedical Inc (LFCR), listing its major individual shareholders and the proportion of shares they hold. It also breaks down shareholder types, such as hedge funds and investment advisors, and provides institutional shareholding data over several quarters, …

Curium in talks to buy Lantheus Holdings for about $7B - Bloomberg (LNTH:NASDAQ)

Curium, backed by CapVest Partners, is reportedly in advanced discussions to acquire radiopharma company Lantheus Holdings (LNTH) for approximately $7 billion. The deal is expected to be announced soon, with Curium offering an upfront payment of around $102 per share and an additional $12.50 …

SCYNEXIS Inc (SCYX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article discusses the revenue breakdown of SCYNEXIS Inc (SCYX) by business segments and regions. However, it states that relevant data for these categories have not yet been disclosed by the company. The page provides current stock information for SCYNEXIS Inc, including its market …

Elanco Seems Best-Positioned Into Q2 Print Among Animal Health Stocks, UBS Says

UBS analysts believe Elanco is the animal health stock best positioned going into Q2 earnings, driven by strong companion animal growth, favorable comparisons, and new product opportunities like Credelio Quattro and potentially Zeneta. While Zoetis faces tough comps and likely flat growth in companion …

Viatris Inc (VTRS) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of Viatris Inc.'s (VTRS) shareholder structure, listing major shareholders and their proportionate holdings, along with institutional ownership trends over recent quarters. It also categorizes shareholders by type and lists ETFs with significant VTRS holdings.

Emergent BioSolutions Inc (EBS) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Emergent BioSolutions Inc (EBS), noting its current valuation score of 9.29 and ranking within the Pharmaceuticals industry. It highlights the company's P/E ratio and mentions that relevant data for P/B, P/S, and P/CF ratios have not yet …

Perrigo Company PLC (PRGO) Income Statement

This article presents the quarterly and annual income statements for Perrigo Company PLC (PRGO), offering detailed financial data including total revenue, cost of revenue, operating expenses, and net income over several years. It provides investors with insights into the company's financial performance and operational …

Akebia Therapeutics Inc (AKBA) Income Statement

This article provides the quarterly and annual income statement for Akebia Therapeutics Inc (AKBA), offering detailed financial data such as total revenue, operating expenses, special income, and net income stretching back to FY2012Q4. It highlights the company's financial performance, including a fiscal year 2025 …

Winners And Losers Of Q1: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Branded Pharmaceuticals Stocks

This article analyzes the Q1 performance of branded pharmaceutical stocks, highlighting Collegium Pharmaceutical as a key example. It discusses industry tailwinds like precision medicine and AI adoption, alongside headwinds such as regulatory scrutiny and patent cliffs. While Collegium Pharmaceutical's revenue beat expectations, its full-year …

ANI Pharmaceuticals Inc (ANIP) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of ANI Pharmaceuticals Inc (ANIP), listing its major shareholders and their respective proportions. It also provides a breakdown of shareholder types by proportion and presents institutional shareholding trends over several quarters, including changes in the number of institutions …

BlackRock (ANIP) discloses 2.9M-share, 12.8% stake in ANI Pharmaceuticals

BlackRock, Inc. has filed an amended beneficial ownership report, disclosing a 12.8% stake in ANI Pharmaceuticals Inc. (ANIP). BlackRock's business units collectively beneficially own 2,899,843 shares of ANI Pharmaceuticals common stock, with sole voting power over 2,860,943 shares and sole dispositive power over all …